PGC1α is a co-activator involved in adaptive thermogenesis, fatty-acid oxidation and gluconeogenesis. We describe the identification of several isoforms of a new human PGC1α homologue, cloned independently and named PGC1β. The human PGC1β gene is localized to chromosome 5, has 13 exons and spans more than 78 kb. Two different 5′ and 3′ ends due to differential splicing were identified by rapid amplification of cDNA ends PCR and screening of human cDNA libraries. We show that PGC1β variants in humans, mice and rats are expressed predominantly in heart, brown adipose tissue, brain and skeletal muscle. PGC1β expression, unlike PGC1α, is not up-regulated in brown adipose tissue in response to cold or obesity. Fasting experiments showed that PGC1α, but not PGC1β, is induced in liver and this suggests that only PGC1α is involved in the hepatic gluconeogenesis. No changes in PGC1β gene expression were observed associated with exercise. Human PGC1β-1a and −2a isoforms localized to the cell nucleus and, specifically, the isoform PGC1β-1a co-activated peroxisome-proliferator-activated receptor-γ, -α and the thyroid hormone receptor β1. Finally, we show that ectopic expression PGC1β leads to increased mitochondrial number and basal oxygen consumption. These results suggest that PGC1β may play a role in constitutive adrenergic-independent mitochondrial biogenesis.
Skip Nav Destination
Article navigation
Research Article|
July 01 2003
Characterization of the human, mouse and rat PGC1beta (peroxisome-proliferator-activated receptor-gamma co-activator 1beta) gene in vitro and in vivo
Aline MEIRHAEGHE;
Aline MEIRHAEGHE
1
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
2To whom correspondence should be addressed (e-mail ajv22@cam.ac.uk).
Search for other works by this author on:
Vivion CROWLEY;
Vivion CROWLEY
1
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
2To whom correspondence should be addressed (e-mail ajv22@cam.ac.uk).
Search for other works by this author on:
Carol LENAGHAN;
Carol LENAGHAN
1
†Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, U.K.
Search for other works by this author on:
Christopher LELLIOTT;
Christopher LELLIOTT
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Kath GREEN;
Kath GREEN
‡MRC Dunn Human Nutrition Unit, Cambridge, U.K.
Search for other works by this author on:
Abigail STEWART;
Abigail STEWART
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Kevin HART;
Kevin HART
†Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, U.K.
Search for other works by this author on:
Sven SCHINNER;
Sven SCHINNER
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Jaswinder K. SETHI;
Jaswinder K. SETHI
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Giles YEO;
Giles YEO
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Martin D. BRAND;
Martin D. BRAND
‡MRC Dunn Human Nutrition Unit, Cambridge, U.K.
Search for other works by this author on:
Ron N. CORTRIGHT;
Ron N. CORTRIGHT
§Departments of Exercise, Sport Science and Physiology, East Carolina University, Greenville, NC 27858, U.S.A.
Search for other works by this author on:
Stephen O'RAHILLY;
Stephen O'RAHILLY
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
Search for other works by this author on:
Carl MONTAGUE;
Carl MONTAGUE
†Cardiovascular and Gastrointestinal Discovery Research Department, AstraZeneca Pharmaceuticals, Macclesfield, U.K.
Search for other works by this author on:
Antonio J. VIDAL-PUIG
Antonio J. VIDAL-PUIG
2
∗Departments of Clinical Biochemistry and Medicine, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K.
2To whom correspondence should be addressed (e-mail ajv22@cam.ac.uk).
Search for other works by this author on:
Biochem J (2003) 373 (1): 155–165.
Article history
Received:
February 03 2003
Revision Received:
March 26 2003
Accepted:
April 04 2003
Accepted Manuscript online:
April 04 2003
Citation
Aline MEIRHAEGHE, Vivion CROWLEY, Carol LENAGHAN, Christopher LELLIOTT, Kath GREEN, Abigail STEWART, Kevin HART, Sven SCHINNER, Jaswinder K. SETHI, Giles YEO, Martin D. BRAND, Ron N. CORTRIGHT, Stephen O'RAHILLY, Carl MONTAGUE, Antonio J. VIDAL-PUIG; Characterization of the human, mouse and rat PGC1beta (peroxisome-proliferator-activated receptor-gamma co-activator 1beta) gene in vitro and in vivo. Biochem J 1 July 2003; 373 (1): 155–165. doi: https://doi.org/10.1042/bj20030200
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.